Market Snapshot:
The Synthetic Biology Service includes services like modify an existing gene or genome or construct a new metabolic pathway. Synthetic biology services include reading, writing, and modifying DNA, among other DNA technologies. Synthetic biology can quickly synthesize DNA sequences without using a DNA template. Synthetic Biology Services identifying possible target genes through library creation to generating, modeling, or engineering cell lines, and optimizing protein expression.
Highlights from Synthetic Biology Service- Market Study
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
The key Players profiled in the report are Thermo Fisher Scientific, Inc. (United States), Merck KGaA (Germany), Agilent Technologies, Inc (United States), Novozymes A/S (Denmark), Ginkgo Bioworks (United States), Amyris (United States), Precigen, Inc. (United States), GenScript (China), Twist Bioscience (United States), Synthetic Genomics (United States), Codexis (United States), Synthego (United States), Creative Enzymes (United States), Eurofins Scientific (Luxembourg), Cyrus Biotechnology (United States), Atum (United States) and TeselaGen (United States). Additionally, other players that are part of this comprehensive study are Arzeda (United States), Integrated DNA Technologies (United States), Royal DSM (Netherlands) and OriGene Technologies (United States).
Geographic Breakdown and Segment Analysis
The Global Synthetic Biology Service- market presents a comprehensive analysis of the Synthetic Biology Service- market by end-user/application (Bio-synthesis, Biofuel and Renewable Energy, Biomaterials and Green Chemicals, Skin Care & Cosmetics, Bioremediation, Biosensing and Others), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Synthetic Biology Service- industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in the geographical region of interest.
For instance, while the holds majority of market share of the Synthetic Biology Service- market
Analyst at AMA have segmented the market study of Global Synthetic Biology Service- market by Type, Application and Region.
Synthetic Biology Service- Market Dynamics:
Attributes | Details |
---|
Growth Drivers | - Rising R&D Funding and Growing Initiatives in Synthetic Biology
- Declining Cost of DNA Sequencing and Synthesizing
|
Influencing Trends | - Biological Development of Biomonitoring and OPX Biotechnologies
|
Restraints | - Biosafety, Biosecurity and Ethical Concerns
|
Gaps & Opportunities | - Investment in Research and Development Investments in Drug Discovery
- Increase in the Need for Protein Therapeutics and Personalized Medicines
|
Market Developments Activities:
On 16 July 2021, Ginkgo go public through a merger with Soaring Eagle acquisition (SRNG), a special-purpose acquisition company, or SPAC. It will be renamed Ginkgo Bioworks Holdings. The aim of that is for the company to make synthesis biology a big part of the planet healthier and sustainable. Large fermentation tanks loaded with genetically re-engineered microorganisms like yeast are frequently use in synthetic biology production, and the final product is filtered out. This manufacturing method consumes very little energy, although it has yet to be proved on a large scale.
On 14 April 2021, the three synthetic biology companies Antheia, Genomatica, and Ginkgo Bioworks announce the launch of SynBio Coalition to drive growth and support for the synthetic biology sector in the United States. The SynBio Coalition intends to help the United States build and grow its advanced biomanufacturing industry, contributing to innovations that will enhance access to medication, create more sustainable and productive farming practices, help transform industrial manufacturing, and unlock the next generation of products, in collaboration with the US federal government.
The Synthetic Biology Service is exploring the market to remain competitive in the market by adopting mergers & acquisitions, expansions, investments, new product launches, and collaborations as their preferred strategies. Its fast expansion can be due to a surge in pharmaceutical and biopharmaceutical businesses. Furthermore, an increasing requirement for regulatory compliance in pharmaceutical and biopharmaceutical companies. Top companies’ massive investments in synthetic biology R&D and strong government support are driving the growth of these markets and making the market more competitive.
Key Target Audience
Synthetic Biology Service Providers, Biotechnology Companies, Pharmaceutical Companies, Research and Development Institutes, Financial Institutes and Investors, Regulatory Bodies and Others